10.1007/s41669-024-00511-9 - Health Technology Assessment Reports ...

This document has been corrected

Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

10.1007/s41669-024-00511-9

Published Online: 2024-08-05

Journal: PharmacoEconomics - Open•Publisher: Springer Science and Business Media LLC

Authors: Amirreza Peyrovinasab•Behnam Sadeghirad•Fatemeh Mirzayeh Fashami•Jean-Eric Tarride•Kimia Hariri•Mitchell Levine

This document has been corrected

10.1007/s41669-024-00511-9

Published Online: 2024-08-05

Journal: PharmacoEconomics - Open

Authors: Amirreza Peyrovinasab•Behnam Sadeghirad•Fatemeh Mirzayeh Fashami•Jean-Eric Tarride•Kimia Hariri•Mitchell Levine

NOW

2024-09-17•Correction

Publisher Correction: Health Technology Assessment Reports for Non-Oncology Medications in Canada from 2018 to 2022: Methodological Critiques on Manufacturers’ Submissions and a Comparison Between Manufacturer and Canadian Agency for Drugs and Technologies in Health (CADTH) Analyses

10.1007/s41669-024-00522-6

* information provided by CrossRef

2024-09-17•Correction

10.1007/s41669-024-00522-6

* information provided by CrossRef

2024-08-05•Published

2024-09-17•Correction

10.1007/s41669-024-00522-6

* information provided by CrossRef

This document has been corrected

10.1007/s41669-024-00511-9

Published Online: 2024-08-05

Journal: PharmacoEconomics - Open•Publisher: Springer Science and Business Media LLC

Authors: Amirreza Peyrovinasab•Behnam Sadeghirad•Fatemeh Mirzayeh Fashami•Jean-Eric Tarride•Kimia Hariri•Mitchell Levine